| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/02/2003 | EP1297847A2 Anti-CD18 antibodies in stroke |
| 04/02/2003 | EP1297843A1 Method of photoreduction of hemoglobin vesicles |
| 04/02/2003 | EP1297839A1 Preventives or remedies for heart failure |
| 04/02/2003 | EP1297833A1 Indole carboxylic acids as thyroid receptor ligands |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 04/02/2003 | EP1297139A2 G-protein coupled receptor org10 |
| 04/02/2003 | EP1297136A2 Full length human hcn1 ih channel subunit and variants |
| 04/02/2003 | EP1297130A2 G-protein coupled receptors |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP1297007A2 Mammalian protein phosphatases |
| 04/02/2003 | EP1296999A2 Neuroactive peptides for treatment of hypoxia and related conditions |
| 04/02/2003 | EP1296996A1 Purine derivatives |
| 04/02/2003 | EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 04/02/2003 | EP1296986A1 5-aminoalkyl-pyrazolo 4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 04/02/2003 | EP1296981A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296959A1 Methods and compositions utilizing quinazolinones |
| 04/02/2003 | EP1296958A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 04/02/2003 | EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 04/02/2003 | EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1296934A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296923A2 Aspirin-triggered lipid mediators |
| 04/02/2003 | EP1296716A2 New formulation |
| 04/02/2003 | EP1296702A1 Neuroprotective peptides |
| 04/02/2003 | EP1296699A1 Therapeutic agents - iii |
| 04/02/2003 | EP1296698A1 Therapeutic agents - ii |
| 04/02/2003 | EP1296697A1 Therapeutic agents - i |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296689A2 Method of administering bisphosphonates |
| 04/02/2003 | EP1296684A2 Treatment of gastroesophageal reflux disease using piperidine derivatives |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1296677A2 Solid valsartan pharmaceutical compositions |
| 04/02/2003 | EP1296675A2 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 04/02/2003 | EP1296674A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 04/02/2003 | EP1296668A2 Compositions based on aminoacids, suitable for improving muscle performance |
| 04/02/2003 | EP1296652A1 Topical pharmaceutical formulations and methods of treatment |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1246627A4 Polyanhydrides with biologically active degradation products |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1192155B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/02/2003 | EP1153033B1 Method for purifying a red fruit extract containing anthocyanosides |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1000027B1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 04/02/2003 | EP0845986B1 Pharmaceutical composition containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine for the treatment of cardiovascular diseases |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | EP0702518B1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407986A Novel imidazotriazinones and the use thereof |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407984A 1,8-naphthyridin-2 (1H)-one derivatives |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407973A Butyne diol derivatives |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407899A Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 04/02/2003 | CN1407892A Intermittent claudication remedies |
| 04/02/2003 | CN1406623A Levulose absorption retardant, compound, food and levulose absorption repressor |
| 04/02/2003 | CN1406619A Transcription against arteriosclerosis |
| 04/02/2003 | CN1406612A Healthy tea against hypertension |
| 04/02/2003 | CN1406609A Chinese medicinal capsules for apoplexy and thoracic palsy and preparation thereof |
| 04/02/2003 | CN1406597A Dakang hypertension capsule |
| 04/02/2003 | CN1406587A Use of activated carbon in oral medicinal preparation for hyperthyroidism |
| 04/02/2003 | CN1406523A Oral liquid production |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104430C Angiogenesis inhibiting pyridazinamines |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104420C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl) phenyl)-4-methyl-2,5-imidazolidin-1-yl) acetylamino)-3-phenyl propionate |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/02/2003 | CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 04/02/2003 | CN1104250C Capsule for regeneration of heart valves |
| 04/02/2003 | CN1104246C Fumigant lotion for treating anorectal disease and preparing process thereof |
| 04/02/2003 | CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties |
| 04/02/2003 | CA2405934A1 Means and method for the treatment of coronary artery obstructions |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541620 Antagonist for tumor necrosis factor; antiinflammatory agents; rheumatic diseases |
| 04/01/2003 | US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |